{
    "id": 28503,
    "fullName": "RIT1 K139N",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "RIT1 K139N does not lie within any known functional domains of the Rit1 protein (UniProt.org). K139N has been potentially associated with drug resistance (PMID: 29636358), but has not been biochemically characterized and therefore, its effect on Rit1 protein function is unknown (PubMed, Apr 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11739,
                    "pubMedId": 29636358,
                    "title": "Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29636358"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6016,
        "geneSymbol": "RIT1",
        "terms": [
            "RIT1",
            "NS8",
            "RIBB",
            "RIT",
            "ROC1"
        ]
    },
    "variant": "K139N",
    "createDate": "07/20/2018",
    "updateDate": "09/27/2019",
    "referenceTranscriptCoordinates": {
        "id": 184115,
        "transcript": "NM_006912",
        "gDna": "chr1:g.155904323T>G",
        "cDna": "c.417A>C",
        "protein": "p.K139N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14604,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a non-small cell lung carcinoma patient harboring EML4-ALK demonstrated resistance to treatment with Xalkori (crizotinib), and was subsequently found to have acquired RIT1 K139N (PMID: 29636358).",
            "molecularProfile": {
                "id": 30275,
                "profileName": "EML4 - ALK RIT1 K139N"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 11739,
                    "pubMedId": 29636358,
                    "title": "Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29636358"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30274,
            "profileName": "RIT1 K139N",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30275,
            "profileName": "EML4 - ALK RIT1 K139N",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 184115,
            "transcript": "NM_006912",
            "gDna": "chr1:g.155904323T>G",
            "cDna": "c.417A>C",
            "protein": "p.K139N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}